Mechanism of resistance and antibacterial susceptibility in extended-spectrum β-lactamase phenotype Klebsiella pneumoniae and Klebsiella oxytoca isolated between 2000 and 2010 in Japan

Journal of Medical Microbiology

Volumn 64, Issue , 2015, Pages 538-543

  Sato, Takafumi ^a   Hara, Takafumi ^a   Horiyama, Tsukasa ^a   Kanazawa, Sachi ^a   Yamaguchi, Takahiro ^a   Maki, Hideki ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFMETAZOLE; CEFTIBUTEN; DORIPENEM; FLOMOXEF; LATAMOXEF; LEVOFLOXACIN; OXY 2 LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL DNA; BETA LACTAM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; JAPAN; KLEBSIELLA OXYTOCA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CROSS INFECTION; DNA, BACTERIAL; HUMANS; JAPAN; KLEBSIELLA INFECTIONS; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION;

EID: 84930974446     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000057     Document Type: Article

References (15)

1. Castanheira, M., Farrell, S. E., Deshpande, L. M., Mendes, R. E. & Jones, R. N. (2013). Prevalence of b-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010). Antimicrob Agents Chemother 57, 3012–3020.
2. Chong, Y., Shimoda, S., Yakushiji, H., Ito, Y., Miyamoto, T., Kamimura, T., Shimono, N. & Akashi, K. (2013). Community spread of extended-spectrum b-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: a long-term study in Japan. J Med Microbiol 62, 1038–1043.
3. CLSI (2012). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that grow Aerobically; Approved Standard, 9th edn, CLSI Document M07-A9. Wayne, PA: Clinical and Laboratory Standards Institute.
4. CLSI (2013). Performance Standards for Antimicrobial Susceptibility Testing; 23rd Informational Supplement M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute.
5. Fournier, B., Lagrange, P. H. & Philippon, A. (1996). b-Lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca. Antimicrob Agents Chemother 40, 460–463.
6. Fournier, B., Gravel, A., Hooper, D. C. & Roy, P. H. (1999). Strength and regulation of the different promoters for chromosomal b-lactamases of Klebsiella oxytoca. Antimicrob Agents Chemother 43, 850–855.
7. Hawkey, P. M. (2008). Prevalence and clonality of extendedspectrum b-lactamases in Asia. Clin Microbiol Infect 14 (Suppl. 1), 159–165.
8. Livermore, D. M. (1995). b-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8, 557–584.
9. Livermore, D.M. (2012).Current epidemiology and growing resistance of Gram-negative pathogens. Korean J Intern Med 27, 128–142.
10. Lob, S. H., Badal, R. E., Bouchillon, S. K., Hawser, S. P., Hackel, M. A. & Hoban, D. J. (2013). Epidemiology and susceptibility of Gramnegative appendicitis pathogens: SMART 2008–2010. Surg Infect (Larchmt) 14, 203–208.
11. Nakamura, T., Komatsu, M., Yamasaki, K., Fukuda, S., Miyamoto, Y., Higuchi, T., Ono, T., Nishio, H., Sueyoshi, N. & other authors (2012). Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum b-lactamases from clinical samples in the Kinki Region of Japan. Am J Clin Pathol 137, 620–626.
12. Pitout, J. D. (2010). Infections with extended-spectrum b-lactamaseproducing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70, 313–333.
13. Rodrìguez-Martìnez, J. M., Poirel, L., Nordmann, P., Fankhauser, C., Francois, P. & Schrenzel, J. (2008). Ceftazidime-resistant Klebsiella oxytoca producing an OXY-2-type variant from Switzerland. Int J Antimicrob Agents 32, 278–279.
14. Yano, H., Uemura, M., Endo, S., Kanamori, H., Inomata, S., Kakuta, R., Ichimura, S., Ogawa, M., Shimojima, M. & other authors (2013). Molecular characteristics of extended-spectrum b-lactamases in clinical isolates from Escherichia coli at a Japanese tertiary hospital. PLoS One 8, e64359.
15. Zhang, Y., Zhou, H., Shen, X. Q., Shen, P., Yu, Y. S. & Li, L. J. (2008). Plasmid-borne armA methylase gene, together with blaCTX-M-15 and blaTEM-1, in a Klebsiella oxytoca isolate from China. J Med Microbiol 57, 1273–1276.